Cargando…

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease

We hypothesized that bronchodilator treatment not only improves hyperinflation and endurance capacity but also muscular efficiency in stable chronic obstructive pulmonary disease (COPD). We aimed to demonstrate that tiotropium and salmeterol improve muscular efficiency compared with placebo. Twenty-...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Vaart, Hester, Postma, Dirkje S, Grevink, René, Roemer, Willem, ten Hacken, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107699/ https://www.ncbi.nlm.nih.gov/pubmed/21660300 http://dx.doi.org/10.2147/COPD.S17482

Ejemplares similares

Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers
por: Willemse, Brigitte WM, et al.
Publicado: (2005)

Association of mast cells with lung function in chronic obstructive pulmonary disease
por: Gosman, Margot ME, et al.
Publicado: (2008)

RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2008)

Retraction Note to: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2009)

Acute effects of cigarette smoking on inflammation in healthy intermittent smokers
por: van der Vaart, Hester, et al.
Publicado: (2005)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease
por: Beeh, Kai M.
Publicado: (2016)

Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Pouwels, Simon D., et al.
Publicado: (2019)

GST-omega genes interact with environmental tobacco smoke on adult level of lung function
por: de Jong, Kim, et al.
Publicado: (2013)

Development, validity and responsiveness of the Clinical COPD Questionnaire
por: van der Molen, Thys, et al.
Publicado: (2003)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Development of a tool to recognize small airways dysfunction in asthma (SADT)
por: Schiphof-Godart, Lieke, et al.
Publicado: (2014)

Reticular basement membrane in asthma and COPD: Similar thickness, yet different composition
por: Liesker, Jeroen JW, et al.
Publicado: (2009)

Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics
por: Telenga, Eef D, et al.
Publicado: (2013)

Severity Staging of Chronic Obstructive Pulmonary Disease: Differences in Pre- and Post-Bronchodilator Spirometry
por: Lin, Sheng-Hsiang, et al.
Publicado: (2009)

The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G.
Publicado: (2018)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
por: Fattahi, Fatemeh, et al.
Publicado: (2013)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
por: Kliber, Agnes, et al.
Publicado: (2010)

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
por: Pisi, Roberta, et al.
Publicado: (2015)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
por: Zhang, Xiaoling, et al.
Publicado: (2020)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
por: Cheng, Shih-Lung
Publicado: (2021)

Can AMP induce sputum eosinophils, even in subjects with complete asthma remission?
por: Volbeda, Franke, et al.
Publicado: (2010)

Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17(+) Cells in Asthmatic Airways
por: Fattahi, Fatemeh, et al.
Publicado: (2016)

Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View
por: Zeneyedpour, Lona, et al.
Publicado: (2019)

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
por: Fujimoto, Keisaku, et al.
Publicado: (2011)

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives Dave Singh
por: Singh, Dave
Publicado: (2015)

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review
por: Lopez-Campos, Jose Luis, et al.
Publicado: (2017)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease
por: Brunner, Wendy M., et al.
Publicado: (2022)

Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator
por: Wang, Wei, et al.
Publicado: (2022)

Changes in the endurance shuttle walk test in COPD patients with chronic respiratory failure after pulmonary rehabilitation: the minimal important difference obtained with anchor- and distribution-based method
por: Altenburg, Wytske A, et al.
Publicado: (2015)

Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers
por: Hoonhorst, Susan J. M., et al.
Publicado: (2014)

Airway wall thickness on HRCT scans decreases with age and increases with smoking
por: Telenga, Eef D., et al.
Publicado: (2017)

Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and meta-analysis
por: Xie, XueQian, et al.
Publicado: (2012)

Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD
por: Hoonhorst, Susan JM, et al.
Publicado: (2014)

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
por: Jenkins, Christine R., et al.
Publicado: (2015)

Advantage of impulse oscillometry over spirometry to diagnose chronic obstructive pulmonary disease and monitor pulmonary responses to bronchodilators: An observational study
por: Saadeh, Constantine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ftmh9h0ms9ahiqugho6vndnjm9